Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
What We Have Here Is A Failure To Communicate
Patients Not Hearing About Recalls Is ECRI’s No. 1 Technology Hazard
Feb 01 2023
•
By
Brian Bossetta
• Source: Shutterstock
More from Regulation
More from Policy & Regulation